EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category  |
Confidence Level |
|---|
    2.6.1.16 | Neoplasms |
28186970 |
High expression of GFAT1 predicts unfavorable prognosis in patients with hepatocellular carcinoma. |
causal interaction
diagnostic usage
unassigned |
4
4
0 |
| 2.6.1.16 | Neoplasms |
31645543 |
Enhanced hexosamine metabolism drives metabolic and signaling networks involving hyaluronan production and O-GlcNAcylation to exacerbate breast cancer. |
causal interaction
diagnostic usage
unassigned |
1
3
0 |
| 2.6.1.16 | Neoplasms |
33517899 |
High GFPT1 expression predicts unfavorable outcomes in patients with resectable pancreatic ductal adenocarcinoma. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
4
3
0 |
| 2.6.1.16 | Diabetes Complications |
17379537 |
Expression and purification of active human internal His(6)-tagged L-glutamine: D-Fructose-6P amidotransferase I. |
ongoing research
unassigned |
2
0 |
| 2.6.1.16 | Lymphatic Metastasis |
27509259 |
Loss of GFAT1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
4
4
4 |
| 2.6.1.16 | Muscular Diseases |
26501342 |
Global N-linked Glycosylation is Not Significantly Impaired in Myoblasts in Congenital Myasthenic Syndromes Caused by Defective Glutamine-Fructose-6-Phosphate Transaminase 1 (GFPT1). |
causal interaction
ongoing research
therapeutic application
unassigned |
1
2
1
0 |
| 2.6.1.16 | Neoplasm Metastasis |
27509259 |
Loss of GFAT1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
4
4
4 |
| 2.6.1.16 | Neoplasms |
8882734 |
Effects of monophosphoryllipid-A on the immunization of mice with keyhole limpet hemocyanin- and muramyldipeptide-ganglioside Gfpt1 conjugates. |
ongoing research
therapeutic application
unassigned |
4
2
0 |
| 2.6.1.16 | Neoplasms |
26715276 |
Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer. |
causal interaction
diagnostic usage
ongoing research
unassigned |
3
4
1
0 |
| 2.6.1.16 | Neoplasms |
27509259 |
Loss of GFAT1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
4
4
4 |
